Molecules
All signalling molecules tracked across rare diseases on Kipine, with evidence-linked profiles and cross-disease expression data.
70 molecules tracked
IL-1β
Central pro-inflammatory cytokine driving systemic inflammation
Caspase-1
Effector protease of the inflammasome; cleaves pro-IL-1β and pro-IL-18
IL-18
Key cytokine uniquely elevated in AOSD; drives MAS and IFN-γ production
IL-6
Pleiotropic cytokine driving acute-phase response and joint destruction
Gasdermin D
Pore-forming protein
NF-κB
Transcription factor
TNF-α
Pro-inflammatory cytokine contributing to systemic inflammation
ASC (PYCARD)
Inflammasome adaptor protein
MYD88
TLR signalling adaptor
NF-kB
Transcription factor driving inflammatory gene expression
NLRP3 inflammasome
Central innate immune sensor driving caspase-1 activation and IL-1β/IL-18 maturation
Serum Amyloid A (SAA)
Acute-phase reactant and amyloid precursor
14-3-3 proteins
Pyrin inhibitory chaperones
AKT / mTOR
Downstream effectors promoting MC proliferation and survival
Anti-C1q IgG autoantibodies
Pathogenic autoantibody
BTK
B-cell receptor kinase
BTK (Bruton's Tyrosine Kinase)
Key signaling kinase downstream of MYD88
C1q
Central autoantigen and complement initiator
C3
Central complement component
C4
Classical pathway component
C5a
Anaphylatoxin and neutrophil chemoattractant
CCL2
Monocyte chemoattractant
CRP
Acute phase protein
CXCR4
Chemokine receptor driving bone marrow homing
DNASE1L3
Extracellular DNA clearance enzyme
Eosinophils
Effector granulocytes
Eotaxin-3 (CCL26)
Eosinophil chemoattractant
Ferritin
Acute-phase reactant and hallmark biomarker; synthesis driven by multiple cytokines
HCK
SRC family kinase transactivated by mutated MYD88
Histamine
Primary vasoactive mediator causing flushing, pruritus, GI symptoms
IFN-γ
Th1 cytokine linking innate and adaptive immunity; drives macrophage activation
IgE
Allergic effector immunoglobulin
IgM (Immunoglobulin M)
Pathogenic paraprotein causing end-organ damage
IgM (monoclonal)
Diagnostic paraprotein
IL-12 (Interleukin-12)
Novel biomarker — consistently elevated and correlates with disease activity
IL-13
Effector cytokine / tissue remodeller
IL-1beta (Interleukin-1 beta)
Pro-inflammatory cytokine elevated in POEMS
IL-25
Epithelial alarmin
IL-33
Epithelial alarmin
IL-4
Type 2 master cytokine
IL-5
Eosinophil survival factor
IL-6 (Interleukin-6)
Upstream inducer of VEGF — overexpressed by clonal plasma cells
ILC2s
Innate type 2 lymphoid cells
Immunoglobulin Lambda Light Chain (IGLV1-44/IGLV1-40)
Monoclonal protein produced by clonal plasma cells — near-universal lambda restriction
IRAK4
Myddosome kinase component
KIT (CD117)
Central oncogenic driver — mutated receptor tyrosine kinase
MAPK pathway
Signalling cascade — enhanced by mutant TNFR1
Mitochondrial ROS
Oxidative stress mediator — inflammasome activator
MRP8/14 (S100A8/A9)
Neutrophil inflammatory markers
MUC5AC
Gel-forming mucin
NLRP3
Inflammasome sensor
NLRP3 (Cryopyrin)
Inflammasome sensor and scaffold
Periostin
Extracellular matrix protein
PI3K
Central kinase in mast cell survival signaling
PKN1/PKN2
Pyrin phosphorylating kinases
Pyrin (MEFV)
Inflammasome sensor protein (mutated in FMF)
RhoA GTPase
Upstream guard target
S. aureus enterotoxins
Superantigen / disease perpetuator
S100A8/A9 (Calprotectin)
Alarmin and DAMP released by activated phagocytes; amplifies TLR4 signaling
SAA (Serum Amyloid A)
Acute phase protein
SCF (Stem Cell Factor / KIT Ligand)
Normal KIT ligand — bypassed in D816V+ disease
STAT5
Key transcription factor in KIT D816V signaling
TGF-beta1 (Transforming Growth Factor beta 1)
Anti-inflammatory cytokine — paradoxically decreased in POEMS
TNF-alpha
Pro-inflammatory cytokine
TNF-alpha (Tumor Necrosis Factor alpha)
Pro-inflammatory cytokine elevated in POEMS
TNFAIP3 (A20)
NF-kB negative regulator (tumour suppressor)
TNFR1 (TNFRSF1A)
Mutated receptor — primary disease gene product
Tryptase
Key diagnostic biomarker and mast cell mediator
TSLP
Epithelial alarmin
VEGF (Vascular Endothelial Growth Factor)
Central pathogenic driver — mediates vascular permeability, edema, organomegaly, neuropathy